|Mauna Kea Technologies SA -- France Stock|| |
EUR 3.16 0.12 3.95%
Director of Operations
Ms. Veronique Dentan serves as Director of Operations at Mauna Kea Technologies SA. She began her career at the Thales Central Laboratory, first as a research engineer, then as Head of the Organic Materials laboratory. She then went to Photonetics, a telecom company sold to GN NetTest in 2000, where she worked as Chief Technical Officer setting up and developping the RD and engineering departments for Optical Components. Before joining Mauna Kea Technologies, Ms. Dentan also spent 2 years at IXsea, a French Company specialized in fiberoptics based inertial sensors where she was responsible for the OCTANS gyrocompass product line. She holds a Ph.D. in NonLinear Optics.
33 1 48 24 03 45 http://www.maunakeatech.com
The company has return on total asset (ROA)
of (35.99) %
which means that it has lost $35.99 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (123.6) %
meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 6.82 M in total debt with debt to equity ratio (D/E) of 83.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Mauna Kea Technologies SA has Current Ratio of 3.35 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Mauna Kea Technologies SA, a medical device company, develops and sells endomicroscopy and optical biopsy for the diagnosis and treatment of cancer and other diseases. The company was founded in 2000 and is headquartered in Paris, France. Mauna Kea operates under Medical Appliances Equipment classification in France and traded on Paris Stock Exchange exchange. It employs 81 people.Mauna Kea Technologies SA (MKEA) is traded on Paris Stock Exchange in France. It is located in 9, rue d'Enghien and employs 81 people.